ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

N4P N4 Pharma Plc

0.80
0.00 (0.00%)
10 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
N4 Pharma Plc LSE:N4P London Ordinary Share GB00BYW8QM32 ORD 0.4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.80 0.75 0.85 0.80 0.80 0.80 50,000 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Drug & Proprietary Stores 0 -1.03M -0.0057 -1.40 1.45M
N4 Pharma Plc is listed in the Drug & Proprietary Stores sector of the London Stock Exchange with ticker N4P. The last closing price for N4 Pharma was 0.80p. Over the last year, N4 Pharma shares have traded in a share price range of 0.625p to 2.00p.

N4 Pharma currently has 181,080,349 shares in issue. The market capitalisation of N4 Pharma is £1.45 million. N4 Pharma has a price to earnings ratio (PE ratio) of -1.40.

N4 Pharma Share Discussion Threads

Showing 2751 to 2775 of 8600 messages
Chat Pages: Latest  116  115  114  113  112  111  110  109  108  107  106  105  Older
DateSubjectAuthorDiscuss
08/3/2018
15:29
One thing is for sure.
With the former top brass of AZ putting their name to Nuvec, there is going to be a lot more attention given to Nuvecs progress at a time when it is being marketed to the world.

hughwilson
08/3/2018
14:31
Good to see you too indeedee Urigem.
escapetohome
08/3/2018
14:24
$178 billion ! 0.1% of that would make this a 100 bagger company - pie in the sky at the moment, but going in the right direction
urigem
08/3/2018
14:21
wheyhey!

nice to see you here escape

urigem
08/3/2018
14:19
BBBBBBBBLLLLLLLLLUUUUUUUUUUUUUEEEEEEEE FFFFFFIIIIIINNNNNNNNIIIIIIIISSSSSSSSHHHHHHHHH!!
escapetohome
08/3/2018
14:08
More press coverage:
hughwilson
08/3/2018
13:49
From Twitter AIM CHAOS#N4P Nuvec growing into a larger beast than I had ever imagined back in 2016! Former Senior Research Scientist at Astra Zeneca to lead its development from now; other major partners on the horizon (Far East and Europe); and total addressable market for Nuvec estimated at $178 bn!
urigem
08/3/2018
13:47
Of the other positive news, the appointment of Andrew Leishman to head up Nuvec shows just how important this division is becoming within the company. The company state that there are no other silica nanoparticle approved products on the market so Nuvec is ahead in what is a $178 billion market and explains the bringing in of the big guns to push the project ahead.
Many more positives and Nuvec now being marketed throughout Europe in a few days.
All positive stuff.

hughwilson
08/3/2018
13:40
With reference to Japan, investors should note that in today's RNS the company state that they are progressing talks with Japanese contacts. As per previous news they have three months support from the British Embassy in Japan to support such talks so I am expecting results within that timeframe.
hughwilson
08/3/2018
13:35
Hugh’s awfully quiet today!!
eddie_yates
08/3/2018
13:10
O/T I was initially tipped off on N4P on the OPTI bb, and I recommend you guys now take a look over there. Another cracking deal was announced earlier this week but doesn't seem to be fully appreciated by the market - yet. Very low cost business model like N4P. Excellent proactive interview with CEO released today.
parob
08/3/2018
13:02
Yasharad, I would guess a combination of impatient traders disappointed that deals haven't come out of Japan, combined with mms promoting sells. We all know this is a solid company and that deals with these companies do not happen over night. They are proving up to everyone the true value of nuvec. Just will take several months to do so. Meanwhile, I do believe there will be rises once the traders are gone. After all, this news deserves a corresponding strengthened SP:))) dyor
ch1rp
08/3/2018
12:45
Andrew Leishman: Andrew Leishman Ph.D., Director With over 15 years in the biotechnology and pharmaceutical industry Andrew has led projects seeking to deliver therapies targeting components of the immune system. He has worked for various small, medium, and large companies and helped deliver agents that are undergoing clinical trials across several therapy areas. Andrew has a strong understanding of the research and development process for small compound, biological, RNA, and cellular approaches which spans target identification/validation, candidate drug delivery, to pharmacology/translational medicine support for clinical trials. With a friendly and professional approach, Andrew has demonstrated ability to work with collaborators across the globe to deliver customer needs
urigem
08/3/2018
12:26
Well done Urigem & best of luck
Here's hoping for 70p by June

eddie_yates
08/3/2018
12:24
Been buying more today, really pleased with the price, increased my holding by about 10% 11094197643952541293955Thanks :-)
urigem
08/3/2018
12:21
I cant understand the price drop. Fair enough about the rns which didnt have enough enough info to support a higher jump. But it also didnt have any negative information too. The aims that they have described and they are going to achieve in their research for dna/rna vaccines delivery are easily achievable. In an active research team, it shouldnt take more than a few months to transfect human primary cells with the novex system, to look at its toxicity etc. So why price drop?
yasharsad
08/3/2018
12:02
How about some N4P magic this afternoon:)))
ch1rp
08/3/2018
10:40
Ok thanks scotty lol
jakleeds
08/3/2018
10:30
Need more concrete news on the commercial partnerships IMO....to move this materially
qs99
08/3/2018
10:25
jak he aint bought anymore just a change in voting rights from 19% to 18.3% due to the extra shares from the exercised warrants
scotty1
08/3/2018
10:24
Space robot just tweeted:#N4P red after a very bullish RNS this AM. You can't make it up!I'd just like to share this chart from a previous big update for Nuvec on 8th Nov.On the day of the RNS release, share price dropped over 8%! However, the very next day it rose 25% and continued the rise for 3 days...?
ch1rp
08/3/2018
10:20
He’s not stupid ...
jakleeds
08/3/2018
10:20
NT buys more shares. That’s good news ...
jakleeds
08/3/2018
10:03
This is about the right level, no news.
escapetohome
08/3/2018
09:32
Another puff piece rns, no difference in outlook now to when they were 11p. Go you rampers, do your best :)
rathean
Chat Pages: Latest  116  115  114  113  112  111  110  109  108  107  106  105  Older

Your Recent History

Delayed Upgrade Clock